These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 26787509
21. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D. Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995 [Abstract] [Full Text] [Related]
23. Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Kozora E, West SG, Maier SF, Filley CM, Arciniegas DB, Brown M, Miller D, Grimm A, Zhang L. J Neurol Sci; 2010 Aug 15; 295(1-2):87-91. PubMed ID: 20546792 [Abstract] [Full Text] [Related]
24. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Isshi K, Hirohata S. Arthritis Rheum; 1998 Oct 15; 41(10):1819-27. PubMed ID: 9778223 [Abstract] [Full Text] [Related]
27. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus. Ercan E, Ingo C, Tritanon O, Magro-Checa C, Smith A, Smith S, Huizinga T, van Buchem MA, Ronen I. Neuroimage Clin; 2015 Oct 15; 8():337-44. PubMed ID: 26106559 [Abstract] [Full Text] [Related]
29. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus. Shi ZR, Tan GZ, Meng Z, Yu M, Li KW, Yin J, Wei KH, Luo YJ, Jia SQ, Zhang SJ, Wu J, Mi XB, Wang L. Arthritis Rheumatol; 2015 Jan 15; 67(1):193-203. PubMed ID: 25307291 [Abstract] [Full Text] [Related]
30. Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study. Park DJ, Takahashi Y, Kang JH, Yim YR, Kim JE, Lee JW, Lee KE, Lee JK, Lee SS. Clin Exp Rheumatol; 2017 Jan 15; 35 Suppl 105(3):54-60. PubMed ID: 28339361 [Abstract] [Full Text] [Related]
35. White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging. Xu J, Cheng Y, Chai P, Lu Z, Li H, Luo C, Li X, Li L, Zhou Q, Chen B, Cao J, Xu X, Shan B, Xu L, Wen J. J Rheumatol; 2010 May 15; 37(5):974-86. PubMed ID: 20231206 [Abstract] [Full Text] [Related]
37. Migrainous phenomena in systemic lupus erythematosus. Brandt KD, Lessell S. Arthritis Rheum; 1978 May 15; 21(1):7-16. PubMed ID: 623696 [Abstract] [Full Text] [Related]
38. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P. Scand J Rheumatol; 2007 May 15; 36(6):442-7. PubMed ID: 18092265 [Abstract] [Full Text] [Related]